Gland Pharma

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue1,5711,7591,8541,8621,903
Expenses1,2871,3721,3481,4271,472
EBITDA398.05498.05624.49550.60553.09
EBIT291.74366.06515.83439.34438.08
Profit Before Tax283.91362.13505.80434.98430.95
Net Profit183.68261.48366.68316.96290.76
Financial Ratios
Operating Profit Margin26.77%27.94%35.83%30.58%30.16%
Net Profit Margin12.35%16.43%21.04%17.61%15.86%
Earning Per Share (Diluted)11.1515.8722.2319.2217.62
Dividends Per Share0.000.000.000.000.00